Thursday, November 21, 2024
11/21/2024
Project Summary The need for efficient methods for the production of well-defined oligosaccharides continues to present a major bottleneck in the field of microbial glycobiology. Although automated oligosaccharide synthesizers have been developed, most rely on solid-phase synthesis, which can limit the chemistry and scale of synthesis available to them. Furthermore, existing automated approaches to oligosaccharide synthesis have focused almost exclusively on glycosylation reactions, and do not address the time-consuming and tedious process of converting monosaccharide feedstocks into fully-substituted glycosyl donors ready for coupling. The incredible number of building blocks required for microbial glycan synthesis also makes keeping every possible block in stock impossible. All these issues could be addressed by the development of automated continuous flow platforms. Continuous flow reactions can be more easily automated than multi-step batch processes and thereby provide greater batch-to-batch reproducibility. Through proper selection of conditions it is also possible to telescope several reactions into a single run. The objective of this proposal is to generate platform technologies for automated continuous flow-based oligosaccharide that is capable of automating every step of oligosaccharide synthesis, from on-demand donor/acceptor production to assembly of these larger molecules into target structures. We will achieve this by pursuing the following Specific Aims. Specific Aim 1 will examine the automated production of glycosylation ready monosaccharides. By telescoping multiple reactions into a single run and designing and controlling the system with open-source MechWolf software, this approach will allow for the construction of these important intermediates from commercial feedstock in much more rapid timescales than is currently possible. This will include developing rapid chemo-enzymatic syntheses of otherwise difficult to access nonulosonic (9-carbon) acid carbohydrate building blocks commonly associated with several pathogenic microbes. In addition, the MechWolf program will provide an open-source chemical repository for optimal conditions for the production of any protected monosaccharide to ensure batch-to-batch reproducibility and on-demand access of these building blocks. Specific Aim 2 will extend this technology to the automated production of oligosaccharides. The flexible and modular nature of continuous flow synthesis will allow for the construction of glycosidic linkages that are not trivial to make on existing platforms and for which few if any enzymes are available. As proof of principle, the system will be used to construct several capsular polysaccharides associated with the ESKAPE pathogen Acinetobacter baumannii; however, these technologies and concepts could be used for the construction of any oligosaccharide. Taken together, the technologies developed through this research will lead to a rapid, robust, reproducible, and affordable method for automated oligosaccharide production with minimal need for human optimization and intervention.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).
